To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: Pilot study using dynamic contrast-enhanced Doppler ultrasound
- 31 October 2006
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 42 (15), 2472-2479
- https://doi.org/10.1016/j.ejca.2006.04.023
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Evolving imaging technology: contrast-enhanced Doppler ultrasound is early and rapid predictor of tumour responseAnnals of Oncology, 2005
- Doppler US with perfusion software and contrast medium injection in the early evaluation of isolated limb perfusion of limb sarcomas: prospective study of 49 casesAnnals of Oncology, 2005
- Levels of angiogenesis and expression of angiogenesis‐related genes are prognostic for organ‐specific metastasis of renal cell carcinomaCancer, 2005
- Renal cell carcinoma: review of novel single-agent therapeutics and combination regimensAnnals of Oncology, 2005
- Epidermal Growth Factor Receptor and Epidermal Growth Factor Receptor Therapies in Renal Cell Carcinoma: Do We Need a Better Mouse Trap?Journal of Clinical Oncology, 2004
- Validation of a New Method for Quantifying In Vivo Murine Tumor Necrosis by SonographyInvestigative Radiology, 2004
- Response assessment classification in patients with advanced renal cell carcinoma treated on clinical trialsCancer, 2003
- Tumor Regression by Targeted Gene Delivery to the NeovasculatureScience, 2002
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- New Hemodynamic Approach to AngiogenesisInvestigative Radiology, 1999